1-20 of 218
Elisabetta Abruzzese
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Searching for a myelodysplastic syndrome stem cells (MDS-SCs) signature by flow cytometry: Toward a new prognostic tool?

Free
Paola Pacelli, Emanuele Pacini, Anna Sicuranza, Mariachiara Cuccaro, Adele Santoni, Cristina Marzano, Anna Zannoli, Mattia Bello, Donatella Raspadori, Marzia Defina, Elisabetta Abruzzese, Monica Bocchia
Journal: Blood
Blood (2025) 146 (Supplement 1): 5615.
https://doi.org/10.1182/blood-2025-5615
Published: 2025
Journal Articles

Patient engagement and perceived impact of clinical trials in hematology

Free
Elisabetta Abruzzese, Malgorzata Trawinska, Veronica Conti, Raoul Patricelli, Vittoria Sabia, Alessia Tarantino, Rosaria Di Carlo, Paolo De Fabritiis
Journal: Blood
Blood (2025) 146 (Supplement 1): 8160.
https://doi.org/10.1182/blood-2025-8160
Published: 2025
Journal Articles

Durable efficacy and long-term safety with pelabresib plus ruxolitinib in JAK Inhibitor–Naive myelofibrosis: 96-week Results from the Phase III MANIFEST-2 study

Free
Raajit Rampal, John Mascarenhas, Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron Gerds, Francesca Palandri, Vikas Gupta, Sung-Eun Lee, Alessandro Lucchesi, Andrew Kuykendall, Stephen Oh, Andrea Patriarca, alberto Alvarez-Larran, David Lavie, Moshe Talpaz, Jean-Jacques Kiladjian, Ruben Mesa, Monika Wroclawska, Xuechan Li, Thomas Lehmann, Harald Maier, Claire Harrison, Alessandro Vannucchi
Journal: Blood
Blood (2025) 146 (Supplement 1): 910.
https://doi.org/10.1182/blood-2025-910
Published: 2025
Journal Articles

Prognostic impact of persistent and treatment-emergent cytopenia in 879 myelofibrosis patients treated with ruxolitinib: The “RUX-MF” study

Free
Francesca Palandri, Filippo Branzanti, Massimiliano Bonifacio, Elena Maria Elli, Elisabetta Abruzzese, Erika Morsia, Mirko Farina, Mario Tiribelli, Giulia Benevolo, Eloise Beggiato, Bruno Martino, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Alessandra Iurlo, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Andrea Duminuco, Daniele Cattaneo, Roberto Lemoli, Costanza Bosi, Monica Bocchia, Fabrizio Pane, Chiara Sartor, Florian Heidel, Massimo Breccia, Giuseppe Palumbo
Journal: Blood
Blood (2025) 146 (Supplement 1): 3806.
https://doi.org/10.1182/blood-2025-3806
Published: 2025
Journal Articles

Changes in disease responses after discontinution of tyrosine kinase inhibitors (TKI) for pregnancy in established chronic myeloid leukaemia (CML): Evidence for the basis of advice for women of child-bearing age

Free
Jenny Chan, Harry Robertson, Afzal Khan, Samah Alimam, Nauman Butt, Jenny Byrne, Ashlyn Chee, Simone Claudiani, Mhairi Copland, Nick Duncan, Fiona Fernando, Guy Hannah, Andrew Innes, Ali Mahdi, Andrew McGregor, Alexandra Neufeld, Heather Oakervee, Manoj Raghavan, Dragana Milojkovic, Michael Mauro, Susanne Saussele, Elisabetta Abruzzese, Jane Apperley
Journal: Blood
Blood (2025) 146 (Supplement 1): 3784.
https://doi.org/10.1182/blood-2025-3784
Published: 2025
Journal Articles

Efficacy and safety of luspatercept (LUSPA) versus placebo (PBO) in patients (pts) with myelofibrosis (MF) on Janus kinase 2 inhibitor (JAKi) therapy who require red blood cell transfusions (RBCT): primary analysis of the Phase 3 randomized INDEPENDENCE trial

Free
Francesco Passamonti, Jean-Jacques Kiladjian, John Mascarenhas, Claire Harrison, Ruben Mesa, Elisabetta Abruzzese, Harinder Gill, Stefan Wickenhauser, Je-Hwan Lee, Zhijian Xiao, Fabrizio Pane, Suning Chen, Chunting Zhao, Argiris Symeonidis, Fabian Sanabria, Julie Vienne Buerki, Ana Carolina Giuseppi, Jiahui Li, Patricia Martin-Regueira, Haifa Kathrin Al-Ali
Journal: Blood
Blood (2025) 146 (Supplement 1): 907.
https://doi.org/10.1182/blood-2025-907
Published: 2025
Journal Articles

International, prospective study comparing nilotinib versus imatinib with early switch to nilotinib to obtain sustained treatment-free remission (TFR) in patients with chronic myeloid leukemia: The tfr rate at the end of follow-up

Free
Massimo Breccia, Fausto Castagnetti, Elisabetta Abruzzese, Renato Bassan, Gianni Binotto, Massimiliano Bonifacio, Giovanni Caocci, Isabella Capodanno, Francesco Cavazzini, Giuseppe Cimino, Paola Fazi, Antonella Gozzini, Alessandra Iurlo, Jeroen Janssen, Monia Lunghi, Roberto Marasca, Bruno Martino, Monica Messina, Francesco Muriano, Francesca Paoloni, Alfonso Piciocchi, Gianantonio Rosti, Antonella Russo Rossi, Giuseppe Saglio, Simona Sica, Simona Soverini, Agostino Tafuri, Daniele Vallisa, Peter Westerweel, Fabrizio Pane
Journal: Blood
Blood (2025) 146 (Supplement 1): 905.
https://doi.org/10.1182/blood-2025-905
Published: 2025
Journal Articles

Asciminib and pregnancy in CML: Preliminary human data and clinical implications from 47 reported outcomes

Free
Elisabetta Abruzzese, Ekaterina Chelysheva, Delphine Rea, Katia Pagnano, Mohamed Yassin, Nithya Agrawal, Malgorzata Trawinska, Anna Turkina, Jane Apperley, Paolo De Fabritiis
Journal: Blood
Blood (2025) 146 (Supplement 1): 5566.
https://doi.org/10.1182/blood-2025-5566
Published: 2025
Journal Articles

How I Manage Chronic Myeloid Leukemia During Pregnancy

Available to Purchase
Elisabetta Abruzzese, Ekaterina Chelysheva
Journal: Blood
Blood blood.2024026513.
https://doi.org/10.1182/blood.2024026513
Published: 2025
Journal Articles

Assessment of Transitioning from High-Potency to Low-Potency Inhibitors in Chronic Myeloid Leukemia (CML) Patients: The Downgrading-Impact Project, a CML Campus Study

Free
Elisabetta Abruzzese, Simona Bernardi, Uros Markovic, Malgorzata Monika Trawinska, Sara Barulli, Alessandro Maggi, Sara Galimberti, Cristina Bucelli, Daniele Sannipoli, Mariella D'Adda, Elena Chiara, Massimiliano Bonifacio, Antonella Russo Rossi, Germana Beltrami, Sabina Russo, Elena Crisa', Grazia Sanpaolo, Francesco Cavazzini, Giuseppina Loglisci, Carmen Fava, Federica Maria Catania, Anna Rita Scortechini, Barbara Scappini, Giovanna Rege Cambrin, Gianni Binotto, Monica Bocchia, Davide Facchinelli, Ambra Di Veroli, Sara Pasquina Pascale, Annapaola Leporace, Matia Bernardi, Monica Crugnola
Journal: Blood
Blood (2024) 144 (Supplement 1): 4532.
https://doi.org/10.1182/blood-2024-211476
Published: 2024
Journal Articles

FATE and Role of Peripheral Blood CD26+ Leukemia STEM CELLS at Diagnosis in Chronic Myeloid Leukemia Patients: FINAL Results of Prospective Flowers Study

Free
Anna Sicuranza, Adele Santoni, Paola Pacelli, Sara Freducci, Emanuele Pacini, Elisabetta Abruzzese, Daniele Cattaneo, Alessandra Iurlo, Luigiana Luciano, Sara Galimberti, Valentina Giai, Olga Mulas, Giovanni Caocci, Federica Sorà, Isabella Capodanno, Monica Crugnola, Antonella Gozzini, Sabina Russo, Mario Annunziata, Claudio Fozza, Anna Marina Liberati, Alessandra Cartocci, Elisabetta Zappone, Emanuele Cencini, Vincenzo Sammartano, Elena Bestoso, Cristina Marzano, Dania Tocci, Teresa Miracapillo, Camilla Turriziani, Donatella Raspadori, Monica Bocchia
Journal: Blood
Blood (2024) 144 (Supplement 1): 995.
https://doi.org/10.1182/blood-2024-204689
Published: 2024
Journal Articles

The Impact of Ponatinib on Pregnancy Outcomes

Free
Elisabetta Abruzzese, Ekaterina Chelysheva, Mouna Bardey-Kanaan, Romuald Soichez, Nhan Thanh Nguyen, Deborah Kelly, Federica Rizzo, Petros Patos, Jane Apperley
Journal: Blood
Blood (2024) 144 (Supplement 1): 2435.
https://doi.org/10.1182/blood-2024-200186
Published: 2024
Journal Articles

Evaluating the Impact of Cross-over from Imatinib to Nilotinib on the Overall Survival in Chronic Myeloid Leukemia Using Inverse Probability of Censoring Weighting: Results from the Gimema Sustrenim Study

Free
Alfonso Piciocchi, Giovanni Marsili, Ylenia Belperio, Monica Messina, Francesca Paola Paoloni, Stefano Soddu, Isabella Capodanno, Rosaria Sancetta, Elisabetta Abruzzese, Alessandro Pulsoni, Monia Lunghi, Giovanni Caocci, Fausto Castagnetti, Paola Fazi, Marco Vignetti, Massimo Breccia, Fabrizio Pane
Journal: Blood
Blood (2024) 144 (Supplement 1): 4530.
https://doi.org/10.1182/blood-2024-198366
Published: 2024
Journal Articles

Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia: Observational Study of 673 Patients in Italy

Free
Valentina Bonuomo, Emanuele Koumantakis, Selene Grano, Paola Berchialla, Fausto Castagnetti, Bruno Martino, Chiara Elena, Monica Bocchia, Isabella Capodanno, Tamara Intermesoli, Maria Cristina Miggiano, Carlo Gambacorti-Passerini, Alessandra Iurlo, Francesca Lunghi, Luigiana Luciano, Elisabetta Abruzzese, Angelo Michele Carella, Massimo Breccia, Felicetto Ferrara, Sabrina Leonetti Crescenzi, Barbara Scappini, Marco De Gobbi, Federica Sorà, Davide Rapezzi, Debora Luzi, Sara Galimberti, Monica Crugnola, Anna Rita Scortechini, Alessandro Maggi, Massimiliano Bonifacio, Mario Annunziata, Giovanni Caocci, Germana Beltrami, Francesco Cavazzini, Giuseppe Pietrantuono, Leonardo Campiotti, Fabio Stagno, Caterina Musolino, Daniela Cilloni, Giuseppe Saglio, Carmen Fava
Journal: Blood
Blood (2024) 144 (Supplement 1): 3162.
https://doi.org/10.1182/blood-2024-201493
Published: 2024
Journal Articles

Cytopenias and Failure to Use Innovative Therapy Are Main Drivers of Worse Outcome after Discontinuation of Ruxolitinib in Myelofibrosis

Free
Francesca Palandri, Massimo Breccia, Erika Morsia, Giulia Benevolo, Mario Tiribelli, Eloise Beggiato, Mirko Farina, Bruno Martino, Giovanni Caocci, Novella Pugliese, Alessia Tieghi, Monica Crugnola, Gianni Binotto, Francesco Cavazzini, Elisabetta Abruzzese, Alessandro Isidori, Alessandra Dedola, Emilia Scalzulli, Alessia Moioli, Veronica Guglielmana, Santino Caserta, Andrea Duminuco, Roberto Massimo Lemoli, Daniela Cilloni, Monica Bocchia, Fabrizio Pane, Florian Heidel, Elena Maria Elli, Massimiliano Bonifacio, Giuseppe Alberto Palumbo, Filippo Branzanti
Journal: Blood
Blood (2024) 144 (Supplement 1): 6664.
https://doi.org/10.1182/blood-2024-199961
Published: 2024
Journal Articles

Baseline Features, Treatment Choice and Early Frontline TKI Permanent Discontinuation in Patients with Newly Diagnosed Chronic Myeloid Leukemia Aged 50 - 60 Years: A “Campus CML” Study

Free
Roberto Latagliata, Isabella Capodanno, Maria Cristina Miggiano, Cristina Bucelli, Sabrina Leonetti Crescenzi, Sabina Russo, Ida Carmosino, Atelda Romano, Federica Sorà, Massimiliano Bonifacio, Luigiana Luciano, Giovanni Caocci, Giuseppina Loglisci, Chiara Elena, Francesca Lunghi, Rikard Mullai, Immacolata Attolico, Gianni Binotto, Elena Crisà, Paolo Sportoletti, Francesco Cavazzini, Ambra Di Veroli, Anna Rita Scortechini, Anna Paola Leporace, Alessandro Maggi, Monica Crugnola, Fabio Stagno, Marco Santoro, Pamela Murgano, Davide Rapezzi, Debora Luzi, Jolanda Donatella Vincelli, Sara Galimberti, Monica Bocchia, Carmen Fava, Alessandra Malato, Elisabetta Abruzzese, Michele Pizzuti, Alessandra Iurlo, Giuseppe Saglio, Giorgina Specchia, Massimo Breccia, Mario Tiribelli
Journal: Blood
Blood (2024) 144 (Supplement 1): 1772.
https://doi.org/10.1182/blood-2024-207175
Published: 2024
Journal Articles

ASXL1 Mutations at Diagnosis Did Not Impact on the Depth of Molecular Response (MR) and on Treatment-Free Remission (TFR) Eligibility in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Receiving either Nilotinib (NIL) First-Line or Imatinib (IM) with Early Switch to NIL in Case of No Optimal Response in the SUSTRENIM Clinical Trial

Free
Simona Soverini, Sara De Santis, Cecilia Monaldi, Manuela Mancini, Valentina Giai, Marco Cerrano, Isabella Capodanno, Massimiliano Bonifacio, Elisabetta Abruzzese, Alessandra Iurlo, Fausto Castagnetti, Rosaria Sancetta, Luciano Levato, Carmen Fava, Mario Tiribelli, Francesco Cavazzini, Maria Cristina Miggiano, Niccolò Bolli, Agostino Tafuri, Alessandro Lucchesi, Daniele Vallisa, Monia Lunghi, Caterina Musolino, Samantha Bruno, Cristina Mosca, Mauro Ciriello, Giovanni Marsili, Alfonso Piciocchi, Paola Fazi, Michele Cavo, Jeroen J.W.M. Janssen, Peter E. Westerweel, Fabrizio Pane
Journal: Blood
Blood (2024) 144 (Supplement 1): 3158.
https://doi.org/10.1182/blood-2024-205465
Published: 2024
Journal Articles

Treatment-Free Remission in CML Patients Discontinuing Post-First Line Therapy

Free
Selene Grano, Valentina Bonuomo, Emanuele Koumantakis, Paola Berchialla, Fausto Castagnetti, Massimo Martino, Chiara Elena, Monica Bocchia, Isabella Capodanno, Tamara Intermesoli, Maria Cristina Miggiano, Carlo Gambacorti-Passerini, Alessandra Iurlo, Francesca Lunghi, Luigiana Luciano, Elisabetta Abruzzese, Angelo Michele Carella, Massimo Breccia, Felicetto Ferrara, Sabrina Leonetti Crescenzi, Barbara Scappini, Marco De Gobbi, Federica Sorà, Davide Rapezzi, Debora Luzi, Sara Galimberti, Monica Crugnola, Anna Rita Scortechini, Alessandro Maggi, Massimiliano Bonifacio, Mario Annunziata, Giovanni Caocci, Germana Beltrami, Francesco Cavazzini, Giuseppe Pietrantuono, Leonardo Campiotti, Fabio Stagno, Caterina Musolino, Carmen Fava
Journal: Blood
Blood (2024) 144 (Supplement 1): 1778.
https://doi.org/10.1182/blood-2024-200208
Published: 2024
Journal Articles

Updated Results from the Phase 3 Manifest-2 Study of Pelabresib in Combination with Ruxolitinib for Janus Kinase Inhibitor-Naïve Patients with Myelofibrosis

Free
John O. Mascarenhas, Sebastian Grosicki, Dominik Chraniuk, Elisabetta Abruzzese, Prithviraj Bose, Aaron T. Gerds, Alessandro M. Vannucchi, Francesca Palandri, Sung-Eun Lee, Vikas Gupta, Alessandro Lucchesi, Stephen Oh, Andrew T. Kuykendall, Andrea Patriarca, Alberto Alvarez-Larran, Ruben Mesa, Jean-Jacques Kiladjian, Moshe Talpaz, Morgan Harris, Sarah-Katharina Kays, Qing Li, Barbara Brown, Anna-Maria Jegg, Claire Harrison, Raajit Rampal
Journal: Blood
Blood (2024) 144 (Supplement 1): 3178.
https://doi.org/10.1182/blood-2024-193193
Published: 2024
Journal Articles

Revised ELN Criteria in Polycythemia Vera Identify an Increased Risk Phenotype for Thrombotic Events Beyond Conventional Risk Stratification. a Multicenter Cooperative Study

Free
Francesca Palandri, Elena Maria Elli, Giulia Benevolo, Alessandra Dedola, Roberto Latagliata, Erika Morsia, Mario Tiribelli, Francesco Cavazzini, Alessia Tieghi, Mirko Farina, Alessandra D'Addio, Elisabetta Abruzzese, Fabrizio Cavalca, Rikard Mullai, Antonio Cuneo, Bruno Martino, Florian Heidel, Elena Rossi, Massimo Breccia, Valerio De Stefano, Filippo Branzanti
Journal: Blood
Blood (2024) 144 (Supplement 1): 242.
https://doi.org/10.1182/blood-2024-200528
Published: 2024